Exploring Gallium(III) Complexes as Emerging Therapeutic Candidates for Breast Cancer.
2/5 보강
OpenAlex 토픽 ·
Metal complexes synthesis and properties
Synthesis and characterization of novel inorganic/organometallic compounds
Radiopharmaceutical Chemistry and Applications
Despite the clinical success of platinum chemotherapeutics, severe side effects and resistance drive the search for alternative metallodrugs.
APA
Alberto Moreno-Fernández, Elena Domínguez-Jurado, et al. (2026). Exploring Gallium(III) Complexes as Emerging Therapeutic Candidates for Breast Cancer.. Journal of medicinal chemistry, 69(8), 9051-9070. https://doi.org/10.1021/acs.jmedchem.5c03480
MLA
Alberto Moreno-Fernández, et al.. "Exploring Gallium(III) Complexes as Emerging Therapeutic Candidates for Breast Cancer.." Journal of medicinal chemistry, vol. 69, no. 8, 2026, pp. 9051-9070.
PMID
41940724 ↗
Abstract 한글 요약
Despite the clinical success of platinum chemotherapeutics, severe side effects and resistance drive the search for alternative metallodrugs. Gallium compounds are promising due to their ability to mimic iron(III) and disrupt essential cellular processes; however, poor aqueous stability and moderate cytotoxicity have limited their development. Herein, we report a new family of heteroscorpionate gallium(III) salts, [Ga(κ-NNO)][GaCl] (). NMR spectroscopy and single-crystal X-ray diffraction confirmed their molecular structures. The complexes exhibit remarkable air and moisture stability, with tunable lipophilicity and solubility governed by ligand electronics. and , bearing dimethylamino substituents, showed nanomolar cytotoxicity across breast cancer cell lines, outperforming classical platinum drugs. The lead compound displayed high hydrolytic stability, selective tumor-cell uptake, cytoplasmic localization, and significant tumor growth inhibition in zebrafish xenografts without observable systemic toxicity in mice, underscoring the potential of the heteroscorpionate platform.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.